Researchers at Nagoya University in Japan created and improved artificial intelligence (AI) designs to synthesize a candidate compound for a new gastric acid inhibitor with a better binding affinity than existing drugs.
Another Win for Biomarker-Driven Thromboprophylaxis for Patients With Cancer
Biomarker-directed thromboprophylaxis in the outpatient setting significantly reduced the frequency of thromboembolism in high-risk patients with gastrointestinal (GI) or lung cancers, a randomized trial showed.